Literature DB >> 8309590

SOD1 missense mutation in an Italian family with ALS.

I Rainero1, L Pinessi, T Tsuda, M G Vignocchi, G Vaula, L Calvi, P Cerrato, B Rossi, L Bergamini, D R McLachlan.   

Abstract

We have discovered a new Italian pedigree with autosomal-dominant ALS. The pedigree, at present, comprises 75 members distributed in five generations. ALS was diagnosed in eight patients. The mean +/- SD age of onset of the disease was 46.8 +/- 13.5 years, with a range of 29 to 63 years. The mean +/- SD duration of the disease was 11.6 +/- 1.7 months. Molecular genetic studies showed a missense mutation (Gly-->Ser, codon 41) in exon 2 of the Cu/Zn superoxide dismutase gene (SOD1) on chromosome 21 in the available affected member and in 45% of the at-risk subjects of the pedigree. This study confirms the presence of SOD1 point mutations in families with autosomal-dominant ALS and suggests that additional genetic or environmental factors may be involved in the full expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8309590     DOI: 10.1212/wnl.44.2.347

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

2.  SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.

Authors:  Stefania Battistini; Fabio Giannini; Giuseppe Greco; Giuseppe Bibbò; Loreta Ferrera; Valeria Marini; Renzo Causarano; Michela Casula; Giuliana Lando; Maria Cristina Patrosso; Claudia Caponnetto; Paola Origone; Alessandro Marocchi; Alberto Del Corona; Gabriele Siciliano; Paola Carrera; Vincenzo Mascia; Marcello Giagheddu; Carlo Carcassi; Sandro Orrù; Cecilia Garrè; Silvana Penco
Journal:  J Neurol       Date:  2005-03-29       Impact factor: 4.849

3.  Molecular analyses of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan.

Authors:  M Aoki; K Abe; Y Itoyama
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

Review 4.  Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.

Authors:  J de Belleroche; R Orrell; A King
Journal:  J Med Genet       Date:  1995-11       Impact factor: 6.318

5.  Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis.

Authors:  A Pramatarova; D A Figlewicz; A Krizus; F Y Han; I Ceballos-Picot; A Nicole; M Dib; V Meininger; R H Brown; G A Rouleau
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

6.  Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Authors:  Melissa M Haulcomb; Rena M Meadows; Whitney M Miller; Kathryn P McMillan; MeKenzie J Hilsmeyer; Xuefu Wang; Wesley T Beaulieu; Stephanie L Dickinson; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

7.  A Novel Variant in Superoxide Dismutase 1 Gene (p.V119M) in Als Patients with Pure Lower Motor Neuron Presentation.

Authors:  Claudia Ricci; Fabio Giannini; Giulia Riolo; Silvia Bocci; Stefania Casali; Stefania Battistini
Journal:  Genes (Basel)       Date:  2021-09-29       Impact factor: 4.096

8.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.